A press release distributed through GLOBE NEWSWIRE says ResearchedPeptides.ca has been ranked the number one retatrutide supplier in Canada in a 2026 comparison published by Toronto Times. The guide assessed five sources available to Canadian laboratories on analytical transparency and domestic procurement, and the Vancouver company took the top overall placement.
Retatrutide, also known as LY3437943, is a synthetic 39-amino-acid peptide studied as a triple agonist of the GIP, GLP-1 and glucagon receptors. The added glucagon receptor activity is what separates it from dual GIP/GLP-1 agonists such as tirzepatide. The release states plainly that retatrutide is an investigational compound and is not approved for human use.
The purity number
The figure doing the work here is 99.79%, reported by HPLC-UV at 214 nm on a Certificate of Analysis issued by the testing laboratory Testides on May 11, 2026, under report number JSTE-RETA-10-050426. The same document reports a bacterial endotoxin result below 0.125 EU/mL, which the release says passed the USP <85> specification.
According to the release, Toronto Times argued that a specific figure like 99.79% gives a researcher an exact value to record, while a "greater than or equal to 99%" claim only sets a floor. The example given is that samples measuring 99.01% and 99.79% both satisfy the same threshold claim, which is a fair point about how purity marketing works across this entire category.
What a ranking like this is
It is worth being precise about the chain of custody on these claims. A supplier issued a press release about a ranking by a publication, and the analytical result underpinning the ranking comes from a certificate commissioned on that supplier's own batch. None of that is unusual in the research peptide trade, and none of it is independent verification.
The release also credits domestic fulfilment, with orders shipping from British Columbia by Canada Post Xpresspost, typically within two business days across most of Canada, avoiding customs exposure on cross-border orders. Logistics, not chemistry, is doing some of the ranking work.
Bottom line
The release says rankings were determined by the publication, and the products referenced are sold for laboratory research only. The genuinely useful idea buried in a promotional document is that a dated, batch-specific laboratory result tells you more than a threshold claim, and that standard is one buyers in this market could apply to everyone, including the company announcing it.
Comments (0)
Discussion happens on Reddit.
Go to r/PeptideNewsroomQuestions and corrections go to r/PeptideNewsroom.